Rapamycin prevents Parkinson’s in mouse model of incurable neurodegenerative disease
Researchers have discovered why long-term use of L-DOPA (levodopa), the most effective treatment for Parkinson’s disease, commonly leads to a movement problem called dyskinesia, a side effect that can be as debilitating as …